Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02175472 · ClinicalTrials.gov registry record · NA
Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease
A NA study, sponsored by PhotoPharmics.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT02175472 is a NA study that has completed, run by PhotoPharmics. The registered enrollment target is 92 participants.
The verdict
NCT02175472, a NA study, has completed, sponsored by PhotoPharmics.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
Light treatment was originally employed in Parkinson's disease (PD) to determine if it might be effective in treating co-existing symptoms of depression and insomnia. However, a preliminary double-blind study as well as other studies reported significant improvement in both motor and co-existing Parkinsonian symptoms. As of yet, no long term double blind study has validated these findings. This study will use a double-blind design to evaluate the safety and efficacy of a non-invasive light therapy device to be used with ongoing pharmacotherapy for PD, over a six month treatment period.
Interventions
- DEVICE Spectramax light therapy device
- DEVICE Control light device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02175472
The ClinicalTrials.gov registry entry for NCT02175472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhotoPharmics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Spectramax light therapy device is the first listed.
NCT02175472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02175472 about?
NCT02175472 is a clinical study titled "Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease". Light treatment was originally employed in Parkinson's disease (PD) to determine if it might be effective in treating co-existing symptoms of depression and insomnia. However, a preliminary double-blind study as well as other studies reported significant improvement in both motor and co-existing Par...
What is the current status of trial NCT02175472?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2014-06. Estimated completion is 2016-12-23.
What interventions are being tested in trial NCT02175472?
The interventions under investigation include: Spectramax light therapy device (DEVICE), Control light device (DEVICE).
Who is sponsoring clinical trial NCT02175472?
This trial is sponsored by PhotoPharmics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.